[mo_oauth_login]
Summary report
GENNET LABORATORIES AS
Date of report 03.06.2025
GENNET LABORATORIES AS
10210164 -
Registered
Founded in
29.05.1997
Fixed capital
25,000 €
Former names
- aktsiaselts Gennet Lab
VAT
EE100039272
(start 01.01.1994)
| start | end |
|---|---|
| 01.01.1994 | - |
keywords
- tervishoiuinfosüsteem
- haigla infosüsteemid
- majandustarkvara
- kliinilised infosüsteemid
- tootmis- ja finantslahendused
- majandustarkvara lahendused
- tervise infosüsteemid
- ester tervisesüsteem
GENNET LABORATORIES AS
Scores and ratings
Reputation score
5990
What is Reputation score?
Credit Score
Borderline
0.33
Credit score today
Borderline
0.33
2003
year
Open the reports you want to print
Employees and salaries
GENNET LABORATORIES AS
Number of employees and estimated average salaries?
| 2024 II | 2024 III | 2024 IV | 2025 I | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
GENNET LABORATORIES AS
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
GENNET LABORATORIES AS
Decision-makers?
Former decision-makers
Relations:
7
Turnover 2025:
2 747 310 €
Employees:
28
Heiki Sissask
★★★★
......
Credit Score: Trustworthy
Reputation score: 8890
Date of birth: ......
Active relations 7
23 followers
*
GENNET LABORATORIES AS
Former decision-makers?
Relations:
1
Turnover 2025:
2 428 €
Employees:
1
Ülo Kährik
★★★★
......
Credit Score: Trustworthy
Reputation score: 630
Date of birth: ......
Active relations 1
49 followers
Relations:
6
Turnover 2025:
84 278 €
Employees:
2
Asko Berens
★★★★
......
Credit Score: Trustworthy
Reputation score: 2390
Date of birth: ......
Active relations 6
39 followers
Relations:
1
Turnover:
Employees:
Meelis Roosimägi
★★★★
......
Credit Score: Trustworthy
Reputation score: 570
Date of birth: ......
Active relations 1
5 followers
Relations:
1
Turnover 2025:
2 428 €
Employees:
1
Ülo Kährik
★★★★
......
Credit Score: Trustworthy
Reputation score: 630
Date of birth: ......
Active relations 1
49 followers
Relations:
9
Turnover 2025:
6 043 768 €
Employees:
32
Märt Haamer
★★★★
......
Credit Score: Trustworthy
Reputation score: 15300
Date of birth: ......
Active relations 9
253 followers
Relations:
4
Turnover 2025:
3 142 952 €
Employees:
46
ALEKSANDER REITSAKAS
★★★★
......
Credit Score: Neutral
Reputation score: 5020
Date of birth: ......
Active relations 4
101 followers
Relations:
1
Turnover 2025:
2 428 €
Employees:
1
Ülo Kährik
★★★★
......
Credit Score: Trustworthy
Reputation score: 630
Date of birth: ......
Active relations 1
49 followers
GENNET LABORATORIES AS
History of right of representation?
Field
Finance
Business age
28y
Beneficial country:
Estonia
Heiki Sissask
... - ...
Raul Mill
... - ...
Ülo Kährik
... - ...
ALEKSANDER REITSAKAS
... - ...
Märt Haamer
... - ...
Ülo Kährik
... - ...
Meelis Roosimägi
... - ...
Asko Berens
... - ...
Ülo Kährik
... - ...
1997
2001
2005
2009
2013
2017
2021
2025
1997
2000
2002
2005
2007
2010
2012
2015
2017
2020
2022
2025
GENNET LABORATORIES AS
Owners?
Former owners
| Name | Credit Score | Payment | Beginning | Type | Holding |
|---|---|---|---|---|---|
| ...... | ...... | ...... |
100%
|
Former owners
| Name | Credit Score | Payment | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
GENNET LABORATORIES AS
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
GENNET LABORATORIES AS
Subsidiaries and associates?
Former subsidiaries and associates
Beneficiaries
Volumes and values of beneficiaries' assets
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
| Company name | Retained profits | Fixed assets | Balance sheet total | Holdings |
|---|---|---|---|---|
| ...... | ...... | ...... | ...... |
25%
|
| ...... | ...... | ...... | ...... |
25%
|
| ...... | ...... | ...... | ...... |
25%
|
| ...... | ...... | ...... | ...... |
20%
|
| ...... | ...... | ...... | ...... |
33.4%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
32.5%
|
| ...... | ...... | ...... | ...... |
50%
|
| ...... | ...... | ...... | ...... |
50%
|
| ...... | ...... | ...... | ...... |
15%
|
| ...... | ...... | ...... | ...... |
10%
|
| ...... | ...... | ...... | ...... |
50%
|
| ...... | ...... | ...... | ...... |
50%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
| Company name | Retained profits | Fixed assets | Balance sheet total | Holdings |
|---|---|---|---|---|
| ...... | ...... | ...... | ...... |
20%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
30%
|
| ...... | ...... | ...... | ...... |
10%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
28%
|
| ...... | ...... | ...... | ...... |
50%
|
| ...... | ...... | ...... | ...... |
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
| Company name | Retained profits | Fixed assets | Balance sheet total | Holdings |
|---|---|---|---|---|
| ...... | ...... | ...... | ...... |
20%
|
| ...... | ...... | ...... | ...... |
10%
|
| ...... | ...... | ...... | ...... |
1.8%
|
| ...... | ...... | ...... | ...... |
5%
|
| ...... | ...... | ...... | ...... |
100%
|
| ...... | ...... | ...... | ...... |
11.1%
|
| ...... | ...... | ...... | ...... |
10%
|
| ...... | ...... | ...... | ...... |
5.6%
|
| ...... | ...... | ...... | ...... |
Finances and assets
GENNET LABORATORIES AS
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
GENNET LABORATORIES AS
Taxes paid and estimated average salaries| 2022 | 2023 | 2024 | 2025 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
GENNET LABORATORIES AS
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
GENNET LABORATORIES AS
Sales revenue by business arearevenue
| Field of activity | EMTAK code | Sales revenue (2023) | Sales revenue % |
| Programming | 62011 | 2 127 550 € | 100,00 |
GENNET LABORATORIES AS
Sales revenue by country| Turnover EUR | 2023 | 2024 prognosis | 2025 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Finland | ...... | ...... | ...... | |
| Germany | ...... | ...... | ...... | |
| Leed | ...... | ...... | ...... | |
| Lithuania | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
GENNET LABORATORIES AS
Financial indicators and prognosis| Financial indicators | 2023 | 2024 Prognosis | 2025 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| HEALOP PROFESSIONAL OÜ - 50% | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
GENNET LABORATORIES AS
Financial raiting: "SATISFACTORY" (2025 prognosis)| Multipliers and income levels | 2024 prognosis | 2025 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
GENNET LABORATORIES AS
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 15.07.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 07.12.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 30.09.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 30.09.2022 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 11.02.2021 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 30.08.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 04.07.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 30.06.2017 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 21.06.2016 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 18.06.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 10.07.2014 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 22.07.2013 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 18.06.2012 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 30.06.2011 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 30.06.2010 | ...... |
| 2008 | 01.01.2008–31.12.2008 | 17.06.2009 | ...... |
| 2007 | 01.01.2007–31.12.2007 | 05.06.2008 | ...... |
| 2006 | 01.01.2006–31.12.2006 | 26.06.2007 | ...... |
| 2005 | 01.01.2005–31.12.2005 | 30.06.2006 | ...... |
| 2004 | 01.01.2004–31.12.2004 | 22.06.2005 | ...... |
| 2003 | 01.01.2003–31.12.2003 | 25.06.2004 | ...... |
| 2002 | 01.01.2002–31.12.2002 | 27.06.2003 | ...... |
| 2001 | 01.01.2001–31.12.2001 | 25.06.2002 | ...... |
| 2000 | 01.01.2000–31.12.2000 | 25.06.2001 | ...... |
Liabilities and debts
GENNET LABORATORIES AS
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
GENNET LABORATORIES AS
Reports and assets-liabilities overview 03.06.2025?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
GENNET LABORATORIES AS
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
GENNET LABORATORIES AS
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
GENNET LABORATORIES AS
Bailiff's enforcement proceedings as of 03.06.2025?
Bailiff's enforcement proceedings MISSING
GENNET LABORATORIES AS
Regulations of the Payment Order Department as of 03.06.2025?
Regulations of the Payment Order Department MISSING
GENNET LABORATORIES AS
Court orders in the register as of 03.06.2025?
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
07.07.2024
Regulation number: Ä 20006100 / M27
Regulation status has entered into force: 07.07.2024
Date of enforcement of order or additional period: 07.07.2024
Regulation status: Jõustunud
Aruandetrahvimäärus
01.12.2023
Regulation number: Ä 20006100 / M26
Regulation status has entered into force: 08.12.2023
Date of enforcement of order or additional period: 01.12.2023
Regulation status: Puudused kõrvaldatud
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
23.08.2023
Regulation number: Ä 20006100 / M25
Regulation status has entered into force: 23.08.2023
Date of enforcement of order or additional period: 23.08.2023
Regulation status: Jõustunud
Korraldav määrus
31.03.2022
Regulation number: Ä 20006100 / M24
Regulation status has entered into force: 31.03.2022
Date of enforcement of order or additional period: 31.03.2022
Regulation status: Jõustunud
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
16.03.2022
Regulation number: Ä 20006100 / M23
Regulation status has entered into force: 29.09.2022
Date of enforcement of order or additional period: 16.03.2022
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
19.03.2021
Regulation number: Ä 20006100 / M22
Regulation status has entered into force: 18.03.2021
Date of enforcement of order or additional period: 19.03.2021
Regulation status: Puudused kõrvaldatud
Eitav kandemäärus
04.02.2021
Regulation number: K 20006100 / 26
Regulation status has entered into force: 19.02.2021
Date of enforcement of order or additional period: 01.03.2021
Regulation status: Jõustunud
GENNET LABORATORIES AS
Decisions of the Consumer Disputes Committee as of 03.06.2025?
Consumer disputes MISSING
GENNET LABORATORIES AS
Court hearings as of 03.06.2025?
Court hearings MISSING
GENNET LABORATORIES AS
Rulings as of 03.06.2025?
Kohtumäärus haldusasjas nr 3-21-276/9
Tartu Halduskohus Tartu kohtumaja
23.02.2021
| Related companies: | |
| Number of the case: | 3-21-276/9 |
| Type of procedure: | Haldusasi |
| Court: | Tartu Halduskohus Tartu kohtumaja |
| Type of solution: | Kohtumäärus |
| Solution subcategory: | Kaebusest loobumise määrus |
| Composition of the Court: | Roby Koik |
| Commencement of the Court case: | 08.02.2021 |
| Type of procedure: | Kohtu I astme menetlus |
| Commencement of proceedings: | 08.02.2021 |
| Court case category: | Riigihanked, Riigihanked |
| Keyword: | - |
| Court decision date: | 23.02.2021 |
| Entry into force: | 06.03.2021 |
| Dissenting opinion: | |
| ECLI identifier: ? |
ECLI:EE:TRHK:2021:3.21.276.2851 |
GENNET LABORATORIES AS
Notices and announcements as of 03.06.2025?
Announcements MISSING
Marketing
Business network
GENNET LABORATORIES AS
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
GENNET LABORATORIES AS
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
13.05.2025
Tax arrears paid
30.04.2025
Transaction occurred
Business sold services/goods to PÄRNU HAIGLA SA for 761€, in the field of "General hospital services"
(In total they have sold PÄRNU HAIGLA SA 2 262 089€ of services/goods since May 2024)
25.04.2025
Transaction occurred
Business sold services/goods to NARVA HAIGLA SA for 11 195€, in the field of "General hospital services"
(In total they have sold NARVA HAIGLA SA 1 337 978€ of services/goods since February 2025)
No monitoring events found.
Failed to load monitoring events.